scholarly article | Q13442814 |
P356 | DOI | 10.1177/000456329703400606 |
P698 | PubMed publication ID | 9367000 |
P2093 | author name string | W D Fraser | |
J L Berry | |||
E B Mawer | |||
B H Durham | |||
P921 | main subject | iodine in medicine | Q28196266 |
iodine | Q1103 | ||
vitamin D | Q175621 | ||
P304 | page(s) | 632-637 | |
P577 | publication date | 1997-11-01 | |
P1433 | published in | Annals of Clinical Biochemistry | Q15716536 |
P1476 | title | Measurement of plasma 1,25 dihydroxyvitamin D using a novel immunoextraction technique and immunoassay with iodine labelled vitamin D tracer. | |
P478 | volume | 34 ( Pt 6) |
Q44190514 | A parallel group double-blind RCT of vitamin D3 assessing physical function: is the biochemical response to treatment affected by overweight and obesity? |
Q50795081 | Annual change in bone mineral density in predialysis patients with chronic renal failure: significance of a decrease in serum 1,25-dihydroxy-vitamin D. |
Q47718940 | Ascorbic acid-induced chondrocyte terminal differentiation: the role of the extracellular matrix and 1,25-dihydroxyvitamin D. |
Q33991467 | Assessment and interpretation of circulating 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D in the clinical environment |
Q34983624 | Associations of vitamin D pathway genes with circulating 25-hydroxyvitamin-D, 1,25-dihydroxyvitamin-D, and prostate cancer: a nested case-control study |
Q73117680 | Bone loss after renal transplantation: role of hyperparathyroidism, acidosis, cyclosporine and systemic disease |
Q37762487 | Changes in bone mineral parameters, vitamin D metabolites, and PTH measurements with varying chronic kidney disease stages |
Q79103377 | Changes of bone remodeling immediately after parathyroidectomy for secondary hyperparathyroidism |
Q43775767 | Chronotherapy with active vitamin D3 in aged stroke-prone spontaneously hypertensive rats, a model of osteoporosis |
Q74013713 | Correlation between 25-hydroxyvitamin D3 1 alpha-hydroxylase gene expression in alveolar macrophages and the activity of sarcoidosis |
Q73750840 | Determination of the vitamin D analog EB 1089 (seocalcitol) in human and pig serum using liquid chromatography-tandem mass spectrometry |
Q38451333 | Hip bone loss is attenuated with 1000 IU but not 400 IU daily vitamin D3: a 1-year double-blind RCT in postmenopausal women |
Q44461531 | Hyperparathyroidism and long-term bone loss after renal transplantation |
Q46724857 | Hypocalcemia due to tubular dysfunction in a patient with holoprosencephaly |
Q48295533 | Impact of Conventional Medical Therapy on Bone Mineral Density and Bone Turnover in Adult Patients with X-Linked Hypophosphatemia: A 6-Year Prospective Cohort Study. |
Q57727161 | Phenotype Presentation of Hypophosphatemic Rickets in Adults |
Q43837238 | Sensitive analysis of 1alpha,25-dihydroxyvitamin D3 in biological fluids by liquid chromatography-tandem mass spectrometry |
Q44244572 | Short-term low-dose heparin plus bedrest impairs bone metabolism in pregnant women |
Q48353581 | Stimulation of intestinal calcium absorption by orally administrated vitamin D3 compounds: a prospective open-label randomized trial in osteoporosis |
Q35844249 | The assessment of circulating 25(OH)D and 1,25(OH)2D: where we are and where we are going |
Q44911358 | The clinical significance of serum osteocalcin and N-terminal propeptide of type I collagen in predialysis patients with chronic renal failure |
Q44084808 | Time of day improves efficacy and reduces adverse reactions of vitamin D3 in 5/6 nephrectomized rat. |
Q36741161 | Using genetic proxies for lifecourse sun exposure to assess the causal relationship of sun exposure with circulating vitamin d and prostate cancer risk |
Q38073649 | Vitamin D assays: past and present debates, difficulties, and developments |
Search more.